T1	Date 0 7	In 2013
E1	Date:T1 
T2	Age 11 22	50-year-old
T3	Sex 23 26	man
T4	Clinical_event 35 42	visited
E2	Clinical_event:T4 
T5	Nonbiological_location 43 51	hospital
T6	Sign_symptom 78 82	pain
E3	Sign_symptom:T6 
T7	Biological_structure 73 77	bone
T8	Biological_structure 90 98	left leg
T9	Detailed_description 67 72	local
R1	MODIFY Arg1:T8 Arg2:E3	
R2	MODIFY Arg1:T7 Arg2:E3	
R3	MODIFY Arg1:T9 Arg2:E3	
T10	Date 103 118	August 14, 2013
E4	Date:T10 
T11	Disease_disorder 292 304	osteosarcoma
E5	Disease_disorder:T11 
T12	Detailed_description 279 291	osteoblastic
R4	MODIFY Arg1:T12 Arg2:E5	
T13	Therapeutic_procedure 178 187	resection
E6	Therapeutic_procedure:T13 
T14	Detailed_description 170 177	en bloc
R5	MODIFY Arg1:T14 Arg2:E6	
T15	Sign_symptom 164 169	tumor
E7	Sign_symptom:T15 
T16	Biological_structure 144 163	left distal femoral
R6	MODIFY Arg1:T16 Arg2:E7	
T17	Therapeutic_procedure 192 206	reconstruction
E8	Therapeutic_procedure:T17 
T18	Detailed_description 214 247	modular femoral prosthetic system
R7	MODIFY Arg1:T18 Arg2:E8	
T19	Diagnostic_procedure 249 268	Pathology diagnosis
E9	Diagnostic_procedure:T19 
T20	Medication 339 351	chemotherapy
E10	Medication:T20 
T21	Detailed_description 327 338	neoadjuvant
R8	MODIFY Arg1:T21 Arg2:E10	
T22	Dosage 314 323	One cycle
R9	MODIFY Arg1:T22 Arg2:E10	
T23	Dosage 356 364	4 cycles
T24	Detailed_description 368 376	adjuvant
T25	Medication 377 389	chemotherapy
E11	Medication:T25 
R10	MODIFY Arg1:T24 Arg2:E11	
R11	MODIFY Arg1:T23 Arg2:E11	
T26	Medication 395 406	MAP regimen
E12	Medication:T26 
T27	Medication 418 430	methotrexate
E13	Medication:T27 
T28	Dosage 408 417	high-dose
R12	MODIFY Arg1:T28 Arg2:E13	
R13	SUB_PROCEDURE Arg1:E13 Arg2:E12	
T29	Medication 432 441	cisplatin
E14	Medication:T29 
T30	Medication 447 458	doxorubicin
E15	Medication:T30 
R14	SUB_PROCEDURE Arg1:E14 Arg2:E12	
R15	SUB_PROCEDURE Arg1:E15 Arg2:E12	
T31	Date 482 494	January 2015
E16	Date:T31 
T32	Sign_symptom 498 502	mass
E17	Sign_symptom:T32 
T33	Biological_structure 520 540	left upper crus area
R16	MODIFY Arg1:T33 Arg2:E17	
T34	Sign_symptom 548 558	recurrence
E18	Sign_symptom:T34 
T35	Diagnostic_procedure 576 582	biopsy
E19	Diagnostic_procedure:T35 
T36	Date 586 602	January 23, 2015
E20	Date:T36 
T37	Therapeutic_procedure 633 643	amputation
E21	Therapeutic_procedure:T37 
T38	Biological_structure 621 632	upper femur
R17	MODIFY Arg1:T38 Arg2:E21	
T39	Therapeutic_procedure 688 705	joint replacement
E22	Therapeutic_procedure:T39 
A1	POLARITY E22 NEG
T40	Biological_structure 684 687	hip
R18	MODIFY Arg1:T40 Arg2:E22	
T41	Therapeutic_procedure 713 726	wound healing
E23	Therapeutic_procedure:T41 
T42	Clinical_event 740 768	went back to his normal life
E24	Clinical_event:T42 
T44	Therapeutic_procedure 784 799	artificial limb
E25	Therapeutic_procedure:T44 
#1	AnnotatorNotes E25	not a therapy per se
T45	Medication 832 844	chemotherapy
E26	Medication:T45 
A2	POLARITY E26 NEG
T46	Date 967 984	half a year after
E27	Date:T46 
T47	Sign_symptom 1028 1033	cough
E28	Sign_symptom:T47 
T48	Sign_symptom 1044 1053	tightness
E29	Sign_symptom:T48 
T49	Biological_structure 1038 1043	chest
T50	Detailed_description 1017 1027	occasional
R20	MODIFY Arg1:T50 Arg2:E28	
R21	MODIFY Arg1:T49 Arg2:E29	
T51	Diagnostic_procedure 1073 1092	computed tomography
E30	Diagnostic_procedure:T51 
T52	Diagnostic_procedure 1094 1096	CT
E31	Diagnostic_procedure:T52 
T53	Biological_structure 1067 1072	chest
T54	Detailed_description 1062 1066	thin
R22	MODIFY Arg1:T53 Arg2:E30	
R23	MODIFY Arg1:T54 Arg2:E30	
R24	IDENTICAL Arg1:E31 Arg2:E30	
T55	Date 1115 1128	July 15, 2015
E32	Date:T55 
T56	Sign_symptom 1173 1180	nodules
E33	Sign_symptom:T56 
T57	Biological_structure 1163 1172	pulmonary
T58	Detailed_description 1154 1162	multiple
R25	MODIFY Arg1:T57 Arg2:E33	
R26	MODIFY Arg1:T58 Arg2:E33	
T59	Sign_symptom 1224 1234	metastases
E34	Sign_symptom:T59 
A3	POLARITY E34 UNCERTAIN
T60	Medication 1271 1283	chemotherapy
E35	Medication:T60 
A4	POLARITY E35 NEG
T61	Diagnostic_procedure 1285 1300	Immunophenotype
E36	Diagnostic_procedure:T61 
T62	Sign_symptom 1335 1340	tumor
E37	Sign_symptom:T62 
T63	Detailed_description 1329 1334	CD34+
T64	Detailed_description 1319 1324	CD31+
R27	MODIFY Arg1:T63 Arg2:E37	
R28	MODIFY Arg1:T64 Arg2:E37	
T65	Coreference 1374 1379	cells
E38	Coreference:T65 
R29	IDENTICAL Arg1:E38 Arg2:E37	
T66	Diagnostic_procedure 1403 1423	staining for VEGFR-2
E39	Diagnostic_procedure:T66 
T67	Lab_value 1387 1402	strong positive
R30	MODIFY Arg1:T67 Arg2:E39	
R31	MODIFY Arg1:E38 Arg2:E39	
T68	Medication 1433 1441	Apatinib
E40	Medication:T68 
T69	Dosage 1472 1484	500â€Šmg daily
R32	MODIFY Arg1:T69 Arg2:E40	
T70	Activity 3025 3032	driving
E41	Activity:T70 
T71	Date 1486 1504	Half a month later
E42	Date:T71 
T72	Sign_symptom 1510 1518	symptoms
E43	Sign_symptom:T72 
A5	POLARITY E43 NEG
T73	Sign_symptom 1550 1564	wound necrosis
E44	Sign_symptom:T73 
T74	Detailed_description 1538 1549	progressive
R33	MODIFY Arg1:T74 Arg2:E44	
T75	Therapeutic_procedure 1577 1596	debridement surgery
E45	Therapeutic_procedure:T75 
T76	Therapeutic_procedure 1669 1677	resected
E46	Therapeutic_procedure:T76 
T77	Sign_symptom 1626 1634	enlarged
E47	Sign_symptom:T77 
T78	Biological_structure 1635 1645	lymph node
R34	MODIFY Arg1:T78 Arg2:E47	
T79	Biological_structure 1646 1664	near iliac vessels
R35	MODIFY Arg1:T79 Arg2:T78	
T80	Date 1681 1698	February 24, 2016
E48	Date:T80 
R36	MODIFY Arg1:T78 Arg2:E46	
T81	Diagnostic_procedure 1730 1754	pathological examination
E49	Diagnostic_procedure:T81 
T82	Sign_symptom 1780 1791	hyperplasia
E50	Sign_symptom:T82 
T83	Detailed_description 1767 1779	inflammatory
R37	MODIFY Arg1:T83 Arg2:E50	
T84	Biological_structure 1792 1802	lymph node
R38	MODIFY Arg1:T84 Arg2:E50	
T85	Medication 1804 1812	Apatinib
E51	Medication:T85 
A6	POLARITY E51 NEG
T86	Duration 1851 1858	3 weeks
E52	Duration:T86 
T87	Therapeutic_procedure 1862 1875	wound healing
E53	Therapeutic_procedure:T87 
T88	Diagnostic_procedure 1899 1901	CT
E54	Diagnostic_procedure:T88 
T89	Biological_structure 1893 1898	chest
T90	Detailed_description 1888 1892	thin
R39	MODIFY Arg1:T89 Arg2:E54	
R40	MODIFY Arg1:T90 Arg2:E54	
T91	Date 1916 1931	7 and 11 months
E55	Date:T91 
T92	Clinical_event 1982 1991	follow-up
E56	Clinical_event:T92 
T93	Date 1974 1981	7-month
E57	Date:T93 
T94	Lab_value 2658 2660	PR
#2	AnnotatorNotes T94	partial response
T95	Diagnostic_procedure 2581 2592	measurement
E58	Diagnostic_procedure:T95 
T96	Detailed_description 2574 2580	lesion
R41	MODIFY Arg1:T96 Arg2:E58	
T97	Diagnostic_procedure 2610 2629	RECIST 1.1 standard
E59	Diagnostic_procedure:T97 
R42	SUB_PROCEDURE Arg1:E59 Arg2:E58	
R43	MODIFY Arg1:T94 Arg2:E59	
T98	Disease_disorder 2715 2733	hand-foot syndrome
E60	Disease_disorder:T98 
T99	Severity 2710 2714	mild
R44	MODIFY Arg1:T99 Arg2:E60	
T100	Sign_symptom 2745 2764	high blood pressure
E61	Sign_symptom:T100 
T101	Severity 2738 2744	slight
R45	MODIFY Arg1:T101 Arg2:E61	
T102	Lab_value 2776 2819	well controlled after appropriate treatment
R46	MODIFY Arg1:T102 Arg2:E60	
R47	MODIFY Arg1:T102 Arg2:E61	
T103	Sign_symptom 2831 2841	toxicities
E62	Sign_symptom:T103 
A7	POLARITY E62 NEG
T104	Sign_symptom 2870 2884	adverse events
E63	Sign_symptom:T104 
A8	POLARITY E63 NEG
T105	Severity 2824 2830	severe
R48	MODIFY Arg1:T105 Arg2:E62	
T106	Detailed_description 2852 2869	treatment-related
R49	MODIFY Arg1:T106 Arg2:E63	
T107	Medication 2929 2937	apatinib
E64	Medication:T107 
T108	Sign_symptom 2975 2988	toxic effects
E65	Sign_symptom:T108 
A9	POLARITY E65 NEG
T109	Clinical_event 2994 3018	went back to normal life
E66	Clinical_event:T109 
T111	Detailed_description 3036 3049	automatic car
#3	AnnotatorNotes T111	why is this relevant
R51	MODIFY Arg1:T111 Arg2:E41	
T112	Sign_symptom 2057 2064	lesions
E67	Sign_symptom:T112 
A10	POLARITY E67 NEG
T113	Lab_value 2004 2025	2 out of 5 measurable
T114	Lab_value 2030 2056	9 out of 17 non-measurable
R52	MODIFY Arg1:T114 Arg2:E67	
R53	MODIFY Arg1:T113 Arg2:E67	
T115	Sign_symptom 2099 2105	nodule
E68	Sign_symptom:T115 
T116	Sign_symptom 2131 2138	lesions
E69	Sign_symptom:T116 
T117	Lab_value 2082 2098	1 new measurable
R54	MODIFY Arg1:T117 Arg2:E68	
T118	Lab_value 2110 2130	6 new non-measurable
R55	MODIFY Arg1:T118 Arg2:E69	
T119	Diagnostic_procedure 2209 2253	Response Evaluation Criteria in Solid Tumors
E70	Diagnostic_procedure:T119 
T120	Diagnostic_procedure 2255 2261	RECIST
E71	Diagnostic_procedure:T120 
R56	IDENTICAL Arg1:E71 Arg2:E70	
T121	Detailed_description 2263 2266	1.1
R57	MODIFY Arg1:T121 Arg2:E70	
T122	Lab_value 2189 2191	PD
R58	MODIFY Arg1:T122 Arg2:E70	
T123	Clinical_event 2302 2311	follow-up
E72	Clinical_event:T123 
T124	Date 2293 2301	11-month
E73	Date:T124 
T125	Sign_symptom 2337 2344	lesions
E74	Sign_symptom:T125 
A11	POLARITY E74 NEG
T126	Lab_value 2335 2336	9
R59	MODIFY Arg1:T126 Arg2:E74	
T127	Lab_value 2368 2387	1 measurable nodule
R60	MODIFY Arg1:T127 Arg2:E74	
T128	Lab_value 2392 2416	2 non-measurable lesions
R61	MODIFY Arg1:T128 Arg2:E74	
T129	Lab_value 2464 2489	6 non-measureable lesions
R62	MODIFY Arg1:T129 Arg2:E74	
R63	MODIFY Arg1:T5 Arg2:E2	
*	OVERLAP E1 E2 E3
R64	BEFORE Arg1:E3 Arg2:E4	
*	OVERLAP E4 E7 E6 E8 E9 E5
R65	BEFORE Arg1:E5 Arg2:E10	
*	OVERLAP E10 E11 E12
R66	BEFORE Arg1:E12 Arg2:E16	
*	OVERLAP E16 E17
R67	BEFORE Arg1:E17 Arg2:E18	
*	OVERLAP E18 E19 E20
R68	BEFORE Arg1:E20 Arg2:E21	
*	OVERLAP E21 E22
R69	BEFORE Arg1:E22 Arg2:E23	
R70	BEFORE Arg1:E23 Arg2:E24	
*	OVERLAP E24 E25 E26
R71	BEFORE Arg1:E26 Arg2:E27	
*	OVERLAP E27 E28 E29
R72	BEFORE Arg1:E29 Arg2:E30	
*	OVERLAP E30 E32 E33 E34 E35 E36 E37 E38 E39
R73	BEFORE Arg1:E39 Arg2:E40	
R74	BEFORE Arg1:E40 Arg2:E42	
*	OVERLAP E42 E43 E44
R75	BEFORE Arg1:E44 Arg2:E45	
*	OVERLAP E45 E47 E46 E48 E49 E50
R76	BEFORE Arg1:E50 Arg2:E51	
*	OVERLAP E51 E52 E53
R77	BEFORE Arg1:E53 Arg2:E54	
*	OVERLAP E54 E55 E57 E56 E67 E68 E69 E70
R78	BEFORE Arg1:E70 Arg2:E73	
*	OVERLAP E73 E72 E74 E58 E60 E61 E62 E63
R79	BEFORE Arg1:E63 Arg2:E64	
*	OVERLAP E64 E65 E66 E41
